Some U.S. patients reporting COVID rebounds after taking Pfizer pills

As Paxlovid has become more widely used, some patients have reported that COVID-19 symptoms recurred after completing treatment.

Related Keywords

Germany ,United States ,Toronto ,Ontario ,Canada ,American ,Mikael Dolsten ,William Pao ,Albert Bourla ,Pfizer ,Us Centers For Disease ,Pfizer Inc ,Postmedia Network Inc ,Drug Administration ,Reuters ,Chief Development Officer William Pao ,Executive Albert Bourla ,Disease Control ,Postmedia Network ,Street East ,